Umuthi Omusha We-COVID Owuphefumulayo

A BAMBA MahhalaRelease 1 | eTurboNews | eTN
Isithombe sikaLinda Hohnholz
Ibhalwe ngu Linda Hohnholz

I-CanSino Biologics Inc. namuhla imemezele ukuthi i-Preprints ne-The Lancet, ukusebenzisana phakathi kwenkundla yokwabelana ngocwaningo i-SSRN kanye ne-The Lancet, ishicilele ucwaningo lomtholampilo mayelana nokuphepha kanye nokuqina komzimba komgomo weCanSinoBIO's Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) ye-Inhalation Convidecia™. njenge-booster ye-heterologous. Imiphumela yocwaningo ikhombise ukuthi i-booster ene-heterologous enomthamo owodwa we-Inhalation Convidecia™ kubantu abadala abaneminyaka engu-18 nangaphezulu, abathole imithamo emibili yomgomo we-COVID-19 ongasebenzi, ingadala izinga eliphezulu lamasosha omzimba anciphisa amandla kunalawo anomuthi wokugomela i-COVID-XNUMX. i-homogeneous booster yomuthi wokugoma ongasebenzi.

Umuthi wokugomela we-CanSinoBIO ohogele i-COVID-19 uhlinzeka ngezinzuzo ezihlukile futhi umele isixazululo esisha ekuphenduleni ubhubhane lwe-COVID-19. Ukwelashwa okungenanalithi, okungahlanyisi kuhlose ukuhlinzeka ngokuvikeleka okusheshayo, okujwayelekile kanye nesilinganiso esikhulu ngokuphatha okulula. Umuthi wokugoma ohogeliwe uqeqesha umsebenzi wenkumbulo yokuzivikela komzimba ngokulingisa ukutheleleka kwemvelo kwegciwane, okungagcini nje ngokuvuselela ukuvikeleka kwe-humoral kanye namaselula, kodwa futhi kubangele ngempumelelo ukuzivikela kwe-mucosal ukuze kuzuze ukuvikelwa okuphindwe kathathu, okuphelele.

Ucwaningo lubonise ukuthi ukukhulisa umgomo ongasebenzi nge-Inhalation Convidecia™ kuvuselela ukusabela okuqinile kokuzivikela komzimba ku-mucosal. Izinga le-RBD-specific IgA-binding antibody latholwa ku-serum yezifundo ezinsukwini eziyi-14 ngemuva kokugoma.

Uhlolojikelele Lwezifundo Zomtholampilo

Ucwaningo lwaluhlelwe ngokungahleliwe, lungaboni futhi lulawulwa ngokufanayo, nabahlanganyeli be-420 babelwa ngokungahleliwe kumaqembu amathathu abantu abangu-140. Iqembu elilodwa lathola umthamo owodwa ophansi (0.1 ml) we-Inhalation Convidecia™iqembu elilodwa lathola umthamo owodwa ophezulu (0.2 ml) womgomo ohogeliwe; futhi iqembu lokugcina lithole umuthi wokugoma owawungacushiwe olawulwa ngomjovo ofakwa emisipha. Ucwaningo lubonise ukuphepha kanye nokuzivikela komzimba kwe-Inhalation Convidecia™ njengesithuthukisi kusetshenziswa kuphela umthamo owodwa wesihlanu noma okubili kwesihlanu kwenguqulo yayo ye-intramuscular.

Ukuphepha Okufakazelwe kanye Nempumelelo Komuthi Wokugoma Wokuhogela we-CanSinoBIO

Idatha yemiphumela yokuphepha ibonise ukuthi kube nezigameko ezimbalwa zezehlakalo ezimbi ngemva kwe-heterologous booster ye-Inhalation Convidecia™ kunalezo ezinikezwe isikhuthazi se-homologous somuthi wokugoma ongacushiwe. Azikho izehlakalo ezimbi ezimbi ezibonwe emaqenjini amabili okuhogela umoya ezinsukwini ezingama-28 ngemuva kokusetshenziswa kwe-booster, futhi kwakungekho mibiko yokungalungi kokusebenza kwamaphaphu okubalulekile emtholampilo.

Idatha ye-immunogenicity ibonise ukuthi i-booster ehogeliwe ye-heterologous iveze izinga eliphezulu kakhulu lamasosha omzimba angathathi hlangothi kunalawo ane-booster efanayo yomuthi wokugoma ongacushiwe. Kwakungekho mehluko obalulekile ekuphenduleni kokuzivikela komzimba phakathi kwamaqembu amabili okuhogela, ayephakeme izikhathi ezingu-6.7 kuya kwezingu-10.7 kunalelo elibonwe eqenjini lesithathu eline-booster ye-homologous phakathi kwezinsuku eziyi-14 nezingu-28 ngemva kokudubula kwe-booster. Ukwengeza, izinga lama-antibodies angathathi hlangothi likhuphuke ngosuku lwe-28 ngemuva kwe-booster ephefumulayo ku-6054.1 (95% CI 4584.1, 7995.0) yeqembu le-dose ephansi kanye ne-4221.3 (2976.9, 5985.3) IU / ml yeqembu le-high-dose. Iphinde yabonisa ukuthi i-Inhalation Convidecia™ inikeze izinga eliphezulu lokuvikela okuphambanayo ngokumelene nokwahluka kwe-Delta, okunamazinga aphezulu amasosha omzimba anciphisa amandla atholakala kunaleyo ngemithi yokugoma engacushiwe.

Uma kuqhathaniswa ne-booster engasebenzi, inyuke kakhulu i-2019-nCoV spike protein-specific IFN-γ kanye ne-IL-2 ELISA ingatholwa ezinsukwini eziyi-7 ngemuva kwe-inhalation booster. Izinga lenkulumo le-INF-γ ne-IL-2 eqenjini le-inhalation booster laliyizikhathi eziyisi-6 kuye kweziyi-10 futhi izikhathi ezi-4 kuye kwezingu-5 ukuphakama kunalawo aseqenjini le-booster elingacushiwe, ngokulandelana. Kubonisa ukuthi uma kuqhathaniswa ne-homologous booster engasebenzi yomgomo, i-heterologous booster ehogeliwe ingaheha ngokuphawulekayo impendulo yokuzivikela yeselula yohlobo lwe-Th1, kuyilapho izici ezifana nobulili neminyaka zingenawo umthelela ekuphenduleni kokuzivikela komzimba kweselula.

Ukwengeza, izinga le-RBD-specific ELISA antibody elitholwe i-heterologous booster ehogeliwe laliphezulu kakhulu kunalelo lomuthi wokugoma ongacushiwe we-homologous booster ezinsukwini ezingama-28 ngemuva kokuphathwa, izinga le-RBD antibody eqenjini lokuhogela lomthamo omncane lalicishe libe izikhathi eziyi-13 kunalelo iqembu le-homologous elingacushiwe.

Mayelana umbhali

Isithombe sikaLinda Hohnholz

Linda Hohnholz

Umhleli omkhulu we eTurboNews ezinze eTN HQ.

Bhalisa
Yazisa ngakho
isivakashi
0 Amazwana
Okungaphakathi Okuphakelayo
Buka wonke amazwana
0
Ungathanda imibono yakho, ngicela uphawule.x
Yabelana ku...